The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  August 2018 Next

EFMC Sponsorship rules can be found in the by-laws, point E.

  • EUFEPS Annual Meeting 2018- Crossing Barriers for Future Medicines

    May 24-26, 2018   Athens, Greece

    After celebrating its 25th anniversary this year, EUFEPS is proud and happy to announce the 2018 Annual Meeting to be held in Athens, Greece between May 24-26, 2018 in collaboration with Conference Co-Chair Prof. Panos Macheras supported by University of Athens and with parallel tracks organized by EUFEPS Networks.

    This meeting will be focused on the theme “Crossing Barriers for Future Medicines”. The main track of the meeting will continue throughout the scientific programme on May 24 to 26 covering basic sciences in oral and mucosal drug absorption and transport to innovative medicines and their PK/PD evaluation.

    As the concept of future medicines involves an extensive systems approach for both development and for pre-clinical and clinical evaluation, parallel tracks will be organized by networks and EUFEPS member institutions and societies to discuss different aspects. Among these tracks available to the Athens 2018 participants, Nanomedicines tracks will be organized by EUFEPS Network on Nanomedicine and Hellenic Society on Nanotechnology for Health Sciences HSNanoHS. Biotech and Biosimilars and Manufacturing of Future Medicines tracks will be co-organized with industry, Novel Molecular Targets and New Oncology Drugs track will be held by German Pharmaceutical Society, Personalized Medicine tracks will be organized by EUFEPS Network on Systems Pharmacology and Pharmacogenetics network EPRIN.

    Confirmed Speakers

    • Per Artursson, Uppsala University, Sweden
    • Leslie Benet, University of California, United States 
    • Mansoor Khan, University of Texas A&M, United States  
    • Stefan Knapp, Goethe University Frankfurt, Germany 
    • Ivana Knezevic, WHO Group Lead for Norms and Standards for Biological Technologies, Switzerland 
    • Sir Munir Pirmohamed, University of Liverpool, United Kingdom 
    • Jukka Rantanen, University of Copenhagen, Denmark


    • Physiology of the GI tract relevant for drug absorption
    • Nanomedicines and nanosimilars: How to assess how similar?
    • Performance of dosage forms in the GI tract and impact on drug absorption
    • Nanomedicines: Challenges on the road
    • Drug absorption, dissolution and in-silico modeling-towards prediction paradise?
    • Manufacturing of future medicines
    • Systems pharmacology
    • Biotech and biosimilars
    • Regulatory science: Partnerships looking into the future
    • New drugs in oncology
    • Information on drug absorption in regulatory processes- nice to know vs. need to know
    • EUFEPS Network on Pharmacogenetics Research and Implementation
    • Nanomedicines: the European Platform

    The closing date for abstract submission is March 20, 2018

    For more information please contact: 

30 31 01 02 03 04 05
06 07 08 09 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 01 02
All events   |  Future events

Job portal

MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
read more

Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck